Norvegija -
norvegų -
Statens legemiddelverk
simvastatin bluefish 20 mg
bluefish pharmaceuticals ab - simvastatin - tablett, filmdrasjert - 20 mg
Norvegija -
norvegų -
Statens legemiddelverk
simvastatin bluefish 40 mg
bluefish pharmaceuticals ab - simvastatin - tablett, filmdrasjert - 40 mg
Norvegija -
norvegų -
Statens legemiddelverk
simvastatin bluefish 80 mg
bluefish pharmaceuticals ab - simvastatin - tablett, filmdrasjert - 80 mg
Norvegija -
norvegų -
Statens legemiddelverk
lapatinib newbury 250 mg
newbury pharmaceuticals ab - lapatinib ditosylatmonohydrat - tablett, filmdrasjert - 250 mg
Norvegija -
norvegų -
Statens legemiddelverk
fosrenol 500 mg
takeda pharmaceuticals international ag ireland branch - lantankarbonathydrat - tyggetablett - 500 mg
Norvegija -
norvegų -
Statens legemiddelverk
fosrenol 750 mg
takeda pharmaceuticals international ag ireland branch - lantankarbonathydrat - tyggetablett - 750 mg
Norvegija -
norvegų -
Statens legemiddelverk
fosrenol 1000 mg
takeda pharmaceuticals international ag ireland branch - lantankarbonathydrat - tyggetablett - 1000 mg
Europos Sąjunga -
norvegų -
EMA (European Medicines Agency)
vyxeos liposomal (previously known as vyxeos)
jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukemi, myeloid, akutt - antineoplastiske midler - vyxeos liposomal er indisert for behandling av voksne med nylig diagnostisert, terapi-i forbindelse med akutt myelogen leukemi (t-aml) eller aml med myelodysplasia-relaterte endringer (aml-mrc).
Norvegija -
norvegų -
Statens legemiddelverk
anagrelide aop 0.5 mg
aop orphan pharmaceuticals gmbh - anagrelidhydroklorid monohydrat - kapsel, hard - 0.5 mg
Norvegija -
norvegų -
Statens legemiddelverk
anagrelide bluefish 0.5 mg
bluefish pharmaceuticals ab - anagrelidhydroklorid - kapsel, hard - 0.5 mg